{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:45:43Z","timestamp":1793411143331,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA020703"],"award-info":[{"award-number":["R01 AA020703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AA026939"],"award-info":[{"award-number":["U01 AA026939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA24726"],"award-info":[{"award-number":["R01 AA24726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["BX004594"],"award-info":[{"award-number":["BX004594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019486","name":"Biocodex Microbiota Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX004594"],"award-info":[{"award-number":["BX004594"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jhep.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T22:24:39Z","timestamp":1629757479000},"page":"1465-1475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Intestinal virome and therapeutic potential of bacteriophages in liver disease"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2604-1340","authenticated-orcid":false,"given":"Cynthia L.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4323-7668","authenticated-orcid":false,"given":"Derrick E.","family":"Fouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.08.003_bib1","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.08.003_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.08.003_bib3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jhep.2021.08.003_bib4","first-page":"218","article-title":"The dark side of the gut: virome-host interactions in intestinal homeostasis and disease","author":"Li","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2021.08.003_bib5","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pbio.0040003","article-title":"RNA viral community in human feces: prevalence of plant pathogenic viruses","volume":"4","author":"Zhang","year":"2006","journal-title":"Plos Biol"},{"key":"10.1016\/j.jhep.2021.08.003_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00044-18","article-title":"Cross-Domain and viral interactions in the microbiome","volume":"83","author":"Rowan-Nash","year":"2019","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jhep.2021.08.003_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature09199","article-title":"Viruses in the faecal microbiota of monozygotic twins and their mothers","volume":"466","author":"Reyes","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.08.003_bib8","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1101\/gr.122705.111","article-title":"The human gut virome: inter-individual variation and dynamic response to diet","volume":"21","author":"Minot","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.jhep.2021.08.003_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2021.08.003_bib10","doi-asserted-by":"crossref","first-page":"10400","DOI":"10.1073\/pnas.1601060113","article-title":"Healthy human gut phageome","volume":"113","author":"Manrique","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.08.003_bib11","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.08.003_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-virology-031413-085359","article-title":"Naked viruses that aren't always naked: quasi-enveloped agents of acute hepatitis","volume":"1","author":"Feng","year":"2014","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.jhep.2021.08.003_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41564-020-0727-8","article-title":"Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus","volume":"5","author":"Das","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clinmicnews.2020.10.001","article-title":"Hepatitis A and hepatitis E: clinical and epidemiological features, diagnosis, treatment, and prevention","volume":"42","author":"Webb","year":"2020","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.jhep.2021.08.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0676.1994.tb00001.x","article-title":"Manifestations of Epstein-Barr virus-associated disorders in liver","volume":"14","author":"Markin","year":"1994","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2021.08.003_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1568-9972(03)00053-3","article-title":"Is there a role for viruses in triggering autoimmune hepatitis?","volume":"3","author":"Vento","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2021.08.003_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2353\/ajpath.2006.051296","article-title":"Systemic viral infections and collateral damage in the liver","volume":"168","author":"Adams","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2021.08.003_bib18","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome\u00a0in patients with alcoholic hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.08.003_bib19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal virome signature associated with severity of nonalcoholic fatty liver disease","volume":"159","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.08.003_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/gutjnl-2020-322470","article-title":"Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy","volume":"70","author":"Bajaj","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib21","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1073\/pnas.96.5.2192","article-title":"Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage","volume":"96","author":"Hendrix","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.08.003_bib22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(01)20383-3","article-title":"An investigation on the nature of ulta-microscopic viruses","volume":"2","author":"Twort","year":"1915","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2021.08.003_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.jhep.2021.08.003_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"Sulakvelidze","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2021.08.003_bib25","doi-asserted-by":"crossref","first-page":"a012518","DOI":"10.1101\/cshperspect.a012518","article-title":"Therapeutic and prophylactic applications of bacteriophage components in modern medicine","volume":"4","author":"Adhya","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhep.2021.08.003_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s007050170120","article-title":"Frequency of morphological phage descriptions in the year 2000. Brief review","volume":"146","author":"Ackermann","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.jhep.2021.08.003_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/v13030506","article-title":"A\u00a0roadmap for genome-based phage taxonomy","volume":"13","author":"Turner","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2021.08.003_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.ge.06.120172.001105","article-title":"Developmental pathways for the temperate phage: lysis vs lysogeny","volume":"6","author":"Echols","year":"1972","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jhep.2021.08.003_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/mr.56.3.430-481.1992","article-title":"Bacteriophage lysis: mechanism and regulation","volume":"56","author":"Young","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.jhep.2021.08.003_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw047","article-title":"Diversity of phage infection types and associated terminology: the problem with 'Lytic or lysogenic","volume":"363","author":"Hobbs","year":"2016","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jhep.2021.08.003_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138920110790725311","article-title":"Phage choice, isolation, and preparation for phage therapy","volume":"11","author":"Gill","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jhep.2021.08.003_bib32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1099\/mic.0.067116-0","article-title":"Genetic modifications to temperate Enterococcus faecalis phage Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection","volume":"159","author":"Zhang","year":"2013","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.jhep.2021.08.003_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.1714658115","article-title":"Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria","volume":"115","author":"Kilcher","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.08.003_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tim.2015.01.006","article-title":"Revisiting phage therapy: new applications for old resources","volume":"23","author":"Nobrega","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.femsre.2003.08.001","article-title":"Ecology of prokaryotic viruses","volume":"28","author":"Weinbauer","year":"2004","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jhep.2021.08.003_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AEM.64.2.575-580.1998","article-title":"Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa","volume":"64","author":"Jensen","year":"1998","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/JB.182.2.508-512.2000","article-title":"The C-terminal portion of the tail fiber protein of bacteriophage lambda is responsible for binding to LamB, its receptor at the surface of Escherichia coli K-12","volume":"182","author":"Wang","year":"2000","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jhep.2021.08.003_bib38","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/JB.188.7.2400-2410.2006","article-title":"Receptor-binding protein of Lactococcus lactis phages: identification and characterization of the saccharide receptor-binding site","volume":"188","author":"Tremblay","year":"2006","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jhep.2021.08.003_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/JB.188.1.55-63.2006","article-title":"Identification of the lower baseplate protein as the antireceptor of the temperate lactococcal bacteriophages TP901-1 and Tuc2009","volume":"188","author":"Vegge","year":"2006","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jhep.2021.08.003_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2958.2011.07931.x","article-title":"Role of bacteriophage SPP1 tail spike protein gp21 on host cell receptor binding and trigger of phage DNA ejection","volume":"83","author":"Vinga","year":"2012","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib41","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1073\/pnas.1119719109","article-title":"Structure of the receptor-binding carboxy-terminal domain of bacteriophage T7 tail fibers","volume":"109","author":"Garcia-Doval","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.08.003_bib42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/jmbi.1996.0281","article-title":"Bacteriophage T4 host range is expanded by duplications of a small domain of the tail fiber adhesin","volume":"258","author":"Tetart","year":"1996","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jhep.2021.08.003_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jbiotec.2004.08.003","article-title":"Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7","volume":"115","author":"Yoichi","year":"2005","journal-title":"J\u00a0Biotechnol"},{"key":"10.1016\/j.jhep.2021.08.003_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.mi.27.100173.001225","article-title":"Bacteriophage receptors","volume":"27","author":"Lindberg","year":"1973","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cels.2015.08.013","article-title":"Engineering modular viral scaffolds for targeted bacterial population editing","volume":"1","author":"Ando","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.jhep.2021.08.003_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.09.062","article-title":"Reprogramming bacteriophage host range through structure-guided design of chimeric receptor binding proteins","volume":"29","author":"Dunne","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2021.08.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.09.015","article-title":"Engineering phage host-range and suppressing bacterial resistance through phage tail fiber mutagenesis","volume":"179","author":"Yehl","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2021.08.003_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00455-21","article-title":"Engineering the modular receptor-binding proteins of Klebsiella phages switches their capsule serotype specificity","volume":"12","author":"Latka","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.jhep.2021.08.003_bib49","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JVI.75.6.2509-2515.2001","article-title":"Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli","volume":"75","author":"Scholl","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2021.08.003_bib50","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.envpol.2009.05.051","article-title":"Environmental pollution by antibiotics and by antibiotic resistance determinants","volume":"157","author":"Martinez","year":"2009","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jhep.2021.08.003_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.jhep.2021.08.003_bib52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Clinical practice. Antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.08.003_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/ps\/84.4.655","article-title":"Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens","volume":"84","author":"Huff","year":"2005","journal-title":"Poult Sci"},{"key":"10.1016\/j.jhep.2021.08.003_bib54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/fpd.2007.0057","article-title":"Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts","volume":"5","author":"Callaway","year":"2008","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.jhep.2021.08.003_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AEM.00785-09","article-title":"Phage therapy to reduce preprocessing Salmonella infections in market-weight swine","volume":"76","author":"Wall","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AEM.01711-08","article-title":"Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods","volume":"75","author":"Guenther","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib57","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/AEM.05493-11","article-title":"Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes","volume":"77","author":"Anany","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4161\/bact.1.2.15662","article-title":"Bacteriophage biocontrol of Listeria monocytogenes on soft ripened white mold and red-smear cheeses","volume":"1","author":"Guenther","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.jhep.2021.08.003_bib59","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/fpd.2010.0734","article-title":"Inactivation of Escherichia coli O157:H7 attached to spinach harvester blade using bacteriophage","volume":"8","author":"Patel","year":"2011","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.jhep.2021.08.003_bib60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijfoodmicro.2011.12.023","article-title":"Biocontrol of Salmonella Typhimurium in RTE foods with the virulent bacteriophage FO1-E2","volume":"154","author":"Guenther","year":"2012","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijfoodmicro.2011.08.015","article-title":"Application of a bacteriophage cocktail to reduce Salmonella Typhimurium U288 contamination on pig skin","volume":"151","author":"Hooton","year":"2011","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib62","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2021.08.003_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.virol.2012.09.002","article-title":"Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh","volume":"434","author":"Sarker","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2021.08.003_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2013.05.022","article-title":"Safety analysis of a Russian phage cocktail: from MetaGenomic analysis to oral application in healthy human subjects","volume":"443","author":"McCallin","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2021.08.003_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1462-2920.13574","article-title":"Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh","volume":"19","author":"Sarker","year":"2017","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhep.2021.08.003_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2021.08.003_bib68","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/ibd.20176","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"13","author":"Rolhion","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2021.08.003_bib69","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gutjnl-2017-314903","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"67","author":"Palmela","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib70","first-page":"840","article-title":"Bacteriophages targeting adherent invasive Escherichia coli strains as a promising new treatment for Crohn\u2019s disease","volume":"11","author":"Galtier","year":"2017","journal-title":"J\u00a0Crohn's Colitis"},{"key":"10.1016\/j.jhep.2021.08.003_bib71","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2021.08.003_bib72","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2021.08.003_bib73","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance","volume":"8","author":"Da Silva","year":"2018","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jhep.2021.08.003_bib74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.numecd.2017.10.014","article-title":"Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: a prospective pilot study","volume":"28","author":"Duarte","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhep.2021.08.003_bib75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.08.003_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2021.08.003_bib77","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.08.003_bib78","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.08.003_bib79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.08.003_bib80","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobil Pancreat Dis Int"},{"key":"10.1016\/j.jhep.2021.08.003_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2021.08.003_bib82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","article-title":"Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis","volume":"34","author":"Lieber","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2021.08.003_bib83","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-14-40","article-title":"Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics","volume":"14","author":"Tuomisto","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2021.08.003_bib85","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.08.003_bib86","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib87","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.08.003_bib88","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jhep.2021.08.003_bib89","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib90","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jhep.2021.08.003_bib91","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: a review","volume":"26","author":"Little","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.08.003_bib92","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis","volume":"50","author":"Ruhlemann","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.08.003_bib93","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"Ruhlemann","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib95","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.08.003_bib96","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib97","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.08.003_bib98","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib99","doi-asserted-by":"crossref","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","article-title":"Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation","volume":"303","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib100","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib101","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.08.003_bib102","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1521-6918(03)00024-6","article-title":"Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut","volume":"17","author":"Wiest","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2021.08.003_bib103","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/infdis\/157.5.1032","article-title":"Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node","volume":"157","author":"Steffen","year":"1988","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhep.2021.08.003_bib104","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/JCM.00516-10","article-title":"Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis","volume":"48","author":"Bert","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2958.2001.02521.x","article-title":"Identification of a genetic determinant responsible for host specificity in Streptococcus thermophilus bacteriophages","volume":"41","author":"Duplessis","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jhep.2021.08.003_bib106","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1073\/pnas.0704624104","article-title":"Dispersing biofilms with engineered enzymatic bacteriophage","volume":"104","author":"Lu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.08.003_bib107","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1111","article-title":"The prospect for bacteriophage therapy in Western medicine","volume":"2","author":"Merril","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2021.08.003_bib108","series-title":"PHAGE Study: Bacteriophages as Novel Prebiotics","author":"Gindin","year":"2017"},{"key":"10.1016\/j.jhep.2021.08.003_bib109","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3390\/nu12082474","article-title":"PHAGE-2 study: supplemental bacteriophages extend Bifidobacterium animalis subsp. lactis BL04 benefits on gut health and microbiota in healthy adults","volume":"12","author":"Grubb","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2021.08.003_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.08.003_bib111","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.08.003_bib112","doi-asserted-by":"crossref","first-page":"32002","DOI":"10.1038\/srep32002","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2021.08.003_bib113","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.08.003_bib114","doi-asserted-by":"crossref","first-page":"1785251","DOI":"10.1080\/19490976.2020.1785251","article-title":"Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients","volume":"12","author":"Lang","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2021.08.003_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8071011","article-title":"Autoimmune hepatitis: shifts in gut microbiota and\u00a0metabolic pathways among Egyptian patients","volume":"8","author":"Elsherbiny","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.jhep.2021.08.003_bib116","doi-asserted-by":"crossref","first-page":"34055","DOI":"10.1038\/srep34055","article-title":"Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2021.08.003_bib117","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A\u00a0gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2021.08.003_bib118","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature14851","article-title":"Decompensated cirrhosis and microbiome interpretation","volume":"525","author":"Bajaj","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.08.003_bib119","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmet.2020.10.015","article-title":"A\u00a0universal gut-microbiome-derived signature predicts cirrhosis","volume":"32","author":"Oh","year":"2020","journal-title":"Cell Metab"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821019978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821019978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:55:27Z","timestamp":1777510527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821019978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0168827821019978"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.08.003","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal virome and therapeutic potential of bacteriophages in liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}